Myelinated axons are the primary target of hemin-mediated oxidative damage in a model of the central nervous system.

Abstract

Iron released from oligodendrocytes during demyelination or derived from haemoglobin breakdown products is believed to amplify oxidative tissue injury in multiple sclerosis (MS). However, the pathophysiological significance of iron-containing haemoglobin breakdown products themselves is rarely considered in the context of MS and their cellular specificity and mode of action remain unclear. Using myelinating cell cultures, we now report the cytotoxic potential of hemin (ferriprotoporphyrin IX chloride), a major degradation product of haemoglobin, is 25-fold greater than equimolar concentrations of free iron in myelinating cultures; a model that reproduces the complex multicellular environment of the CNS. At low micro molar concentrations (3.3 - 10 μM) we observed hemin preferentially binds to myelin and axons to initiate a complex detrimental response that results in targeted demyelination and axonal loss but spares neuronal cell bodies, astrocytes and the majority of oligodendroglia. Demyelination and axonal loss in this context are executed by a combination of mechanisms that include iron-dependent peroxidation by reactive oxygen species (ROS) and ferroptosis. These effects are microglial-independent, do not require any initiating inflammatory insult and represent a direct effect that compromises the structural integrity of myelinated axons in the CNS. Our data identify hemin-mediated demyelination and axonal loss as a novel mechanism by which intracerebral degradation of haemoglobin may contribute to lesion development in MS.

• Authors: Karl Baldacchino, William J Peveler, Leandro Lemgruber, Rebecca Sherrard Smith, Cornelia Scharler, Lorna Hayden, Lina Komarek, Susan L Lindsay, Susan C Barnett, Julia M Edgar, Christopher Linington, Katja Thümmler
• Journal: Experimental neurology (Exp Neurol) Vol. 354 Pg. 114113 (08 2022) ISSN: 1090-2430 [Electronic] United States
• PMID: 35569511 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Chemical References

• Hemin
• Iron

Topics

• Axons (pathology)
• Central Nervous System (pathology)
• Hemin (metabolism, pharmacology)
• Humans
• Iron (metabolism)
• Multiple Sclerosis (pathology)
• Myelin Sheath (pathology)
• Oligodendroglia (metabolism)
• Oxidative Stress